Meropenem how supplied: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 2: Line 2:
{{Meropenem}}
{{Meropenem}}
{{CMG}}
{{CMG}}
==HOW SUPPLIED==
==How Supplied==
MERREM I.V. is supplied in 20 mL and 30 mL injection vials containing sufficient meropenem to deliver 500 mg or 1 g for intravenous administration,
MERREM I.V. is supplied in 20 mL and 30 mL injection vials containing sufficient meropenem to deliver 500 mg or 1 g for intravenous administration,
respectively.  The dry powder should be stored at controlled room temperature 20-25ºC (68-77ºF) [see USP].  
respectively.  The dry powder should be stored at controlled room temperature 20-25ºC (68-77ºF) [see USP].  

Revision as of 01:36, 23 December 2013

Meropenem
MERREM® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
Compatibility, Reconstitution, and Stability
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

How Supplied

MERREM I.V. is supplied in 20 mL and 30 mL injection vials containing sufficient meropenem to deliver 500 mg or 1 g for intravenous administration, respectively. The dry powder should be stored at controlled room temperature 20-25ºC (68-77ºF) [see USP].

500 mg Injection Vial (NDC 0310-0325-20)
1 g Injection Vial (NDC 0310-0321-30)[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050706s022lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.